SIRT6 and diabetic cardiomyopathy: Another paper held that Sirt6-KO cardiomyocyte endothelial cells (CMECs) were discovered to exacerbate diabetic cardiomyopathy, as indicated by aggravated perivascular fibrosis, cardiomyocyte hypertrophy, and decreased cardiac function.